Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Sofia Spampinato

Erasmus University Rotterdam

Research Interests

Explore related searches

Articles (19)

Collaborators (11)

Richard Pötter

Medical University of Vienna

Camilla Kronborg

Aarhus Universitetshospital

JL Boormans

Erasmus University Rotterdam

Peter Hoskin

The University of Manchester

UNITED KINGDOM

Wilma Heemsbergen

Erasmus University Rotterdam

Johannes Knoth

Medical University of Vienna

Liesbeth Boersma

Maastricht Universitair Medisch Centrum+

Yvette Seppenwoolde

Erasmus University Rotterdam

Karen-Lise Garm Spindler

Professor, Chief Consultant

Aarhus University Hospital

Gerd Heilemann

Medical University of Vienna

Marta Pelizzola

Aarhus University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sofia Spampinato

Research Interests

Explore related searches

Articles (19)

Collaborators (11)

Richard Pötter

Camilla Kronborg

JL Boormans

Peter Hoskin

Wilma Heemsbergen

Johannes Knoth

Liesbeth Boersma

Yvette Seppenwoolde

Karen-Lise Garm Spindler

Gerd Heilemann

Marta Pelizzola

Make your next move.

Sofia Spampinato

Research Interests

Explore related searches

Articles (19)

Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life

Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial

Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study)

Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis

Second primary cancer risks in seminoma patients treated with current and previous radiotherapy protocols

Association Between the Regular Use of Vaginal Dilators and/or Sexual Activity and Vaginal Morbidity in Locally Advanced Cervical Cancer Survivors: An EMBRACE-I Study Report

Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy

A simulated annealing-based Bayesian network structure optimization framework for late morbidity prediction with a large prospective dataset

Impact of the Common Terminology Criteria for Adverse Events (CTCAE) evolution on toxicity scoring in gynaecological radiotherapy

Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer

EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer

Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image–Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study

Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors

In Regard to Vittrup et al. Reply

Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients

EviGUIDE - A tool for evidence-based decision making in image-guided adaptive brachytherapy

Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors

Severity and time-weighted gastrointestinal morbidity in cervix cancer: EMBRACE analysis with MOSES

Collaborators (11)

Richard Pötter

Camilla Kronborg

JL Boormans

Peter Hoskin

Wilma Heemsbergen

Johannes Knoth

Liesbeth Boersma

Yvette Seppenwoolde

Karen-Lise Garm Spindler

Gerd Heilemann

Marta Pelizzola

Make your next move.